Tolerance to beta-agonists during acute bronchoconstriction
Authors:
- J.O. CowanJCJ.O. Cowan
- E.M. FlanneryEFE.M. Flannery
- G.P. HerbisonGHG.P. Herbison
- C.R. McLachlanCMC.R. McLachlan
- G.I. TownGTG.I. Town
- D.R. TaylorDTD.R. Taylor
- D R TaylorDTD R Taylor
- 1 August 1999
- journal article
- clinical trial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 14 (2) , 283-287
Abstract
Previous reports suggest that regular use of beta-agonists does not lead to tolerance to their bronchodilator effects. However, most studies have been conducted in stable asthma. This study investigates whether bronchodilator tolerance can be demonstrated during acute bronchoconstriction. Thirty-four asthmatic subjects were treated with 6 weeks inhaled terbutaline (1 mg q.i.d.), budesonide (400 microg, b.i.d.), both drugs or placebo in a randomized, double-blind, cross-over study. After each treatment methacholine was administered to induce a 20% fall in the forced expiratory volume in one second (FEV1). The response to inhaled salbutamol 100, 100, 200 microg at 5 min intervals) was then measured. Dose-response curves were compared using an analysis of covariance. Pre-methacholine FEV1, the highest pre-methacholine FEV1, the fall in FEV1 induced by methacholine and the logarithm of the provocative dose of methacholine required to induce the 20% fall in FEV1 (PD20) were used as covariates. There was a significantly reduced response to salbutamol after 6 weeks terbutaline treatment: the mean (95% confidence intervals (CI)) area under the dose-response curve was reduced by 36% (24, 47) compared to placebo (p<0.0001). The reduction in bronchodilator response was not affected by concomitant treatment with budesonide. Significant tolerance to the bronchodilator effect of inhaled beta-agonists may be demonstrated when tested during acute bronchoconstriction. Continuous treatment with inhaled beta-agonists may lead to a reduced response to emergency beta-agonist treatment during asthma exacerbations.Keywords
This publication has 14 references indexed in Scilit:
- Functional antagonism: tolerance produced by inhaled beta 2 agonists.Thorax, 1996
- Interaction of Inhaled Beta 2 Agonist and Inhaled Corticosteroid on Airway Responsiveness to Allergen and MethacholineAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patientsThe Lancet, 1995
- Tolerance with beta 2‐adrenoceptor agonists: time for reappraisal.British Journal of Clinical Pharmacology, 1995
- Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthmaThe American Journal of Medicine, 1994
- Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in AsthmaNew England Journal of Medicine, 1992
- Beta agonists and asthma mortality: déjà vuClinical & Experimental Allergy, 1991
- Rapid method for measurement of bronchial responsiveness.Thorax, 1983
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975
- Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticusJournal of Allergy, 1969